Oral Session 2-11D Ph+ALL

[OS2-11D-1] Hyper-CVAD with ponatinib for Philadelphia chromosome positive acute lymphoblastic leukemia

Koji Sasaki¹, Hagop Kantarjian¹, Farhad Ravandi¹, Nicholas Short¹, Naval Daver¹, Naveen Pemmaraju¹, Deborah Thomas¹, Musa Yilmaz¹, Tapan Kadia¹, Rebecca Garris¹, Guillermo Garcia-Manero¹, Courtney Dinardo¹, Marina Konopleva¹, Zeev Estrov¹, Nitin Jain¹, William Wierda¹, Vicki Jeanis¹, Jorge Cortes¹, Susan Obrien², Elias Jabbour¹ (1.MD Anderson Cancer Center, Houston, TX, U.S.A., 2.The University of California, Irvine, U.S.A.)